Early Feasibility Clinical Investigation to Assess YntraDose™ as a Neoadjuvant Treatment for LA-PDAC

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Early Feasibility Clinical Investigation to Assess YntraDose™ as a Neoadjuvant Treatment for LA-PDAC	Locally Advanced; Pancreatic Ductal Adenocarcinoma (PDAC); Unresectable	Recruiting	Not applicable	2026-02-19		NCT07155850

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
BetaGlue Therapeutics SpA	1

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Fondazione Policlinico Universitario A. Gemelli, IRCCS	Roma	Italy	2
Guy's & St Thomas' and Kings College Hospitals	London	United Kingdom	1

Clinical trials